NCT04433221 2020-06-16Combination Immunotherapy Targeting SarcomasShenzhen Geno-Immune Medical InstitutePhase 1/2 Unknown20 enrolled
NCT03356782 2020-06-11Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting SarcomasShenzhen Geno-Immune Medical InstitutePhase 1/2 Unknown20 enrolled